In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist
Abstract
Abstract. Accumulating evidences have highlighted histamine and histamine receptors (HRs)-antagonists’ role in immunomodulation. However, the roles of HRs-agonists are still unclear. The present study was therefore designed to delineate the comparative immunotoxic roles of H1-H4-agonist on antibody generation profile in rabbit model. The cohort comprised of seven groups (Group-I negative control, group-II positive control and group-III-VII HRs-agonist-treated) containing 18 (9 male and 9 female) rabbits each. Group-I and group-II received vehicle (sterile distilled water, 1mlkg-1×b.i.d.) intramuscularly. Groups-III-VII (HRs-agonist-treated) received subcutaneous histamine (100µgkg-1) and H1-agonist (HTMT), H2-agonist (amthamine), H3-agonist (R-[-]-α-methylhistamine) and H4-agonist (clobenpropit) each in a dose of 10µgkg-1, respectively, b.i.d. for 10 days (starting from day 1). Groups-II-VII were subsequently immunized with intravenous injection of SRBC at day 3. The estimation of serum immunoglobulins (Ig), IgM and IgG were done by ELISA, and observed at day 0 (pre-immunization) and day 7, 14, 21, 28 and 58 (post-immunization). Results showed that histamine and HRs-agonist could influence a detectable antibody response to SRBC as early as day 7-postimmunization (post-I), which lasted until day 58- post-I. All the results were found statistically significant (p<0.05). To conclude, our results provide evidences that HTMT, amthamine and clobenpropit (H1-, H2- and H4-agonist, respectively) have important role in modulation of antibody generation by enhancing production level, in which HTMT have dominant role, while amthamine and clobenpropit play similar role. Conversely, R-[-]-α-methylhistamine (H3-agonist) have dominant inhibitory role on antibody production.
Key words: Histamine, histamine receptors, agonists, immunomodulation, antibody generation, immunotoxic
Keywords
References
- Shahid M, Tripathi T, Sobia F, et al. Histamine, histamine receptors, and their role in immunomodulation: an updated systematic review. Open Immunol J 2009; 2: 9-41.
- Falus A, Hargita H, Eszter L, et al. Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol 2001; 22: 648-652.
- Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nature Rev Drug Dis 2008; 7: 41-53.
- Huang JF, Thurmond RL. The New Biology of Histamine Receptors. Curr Allergy Asthma Rep 2008; 8: 21-27.
- Ma RZ, Gao J, Meeker ND, et al. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 2002; 297: 620-623.
- Quintana FJ, Buzas E, Prohászka Z, et al. Knock-out of the histidine decarboxylase gene modifies the repertoire of natural autoantibodies. J Autoimmun 2004; 22: 297-305.
- Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413: 420-425.
- Lim HD, van Rijn RM, Ling P, et al. Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist. J Pharmacol Exp Ther 2005; 314: 1310-1321.
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
Trivendra Tripathi
This is me
Mohammad Shahid
This is me
Adil Raza
This is me
Haris M. Khan
This is me
Mashiatullah Siddiqui
This is me
Abida Malik
This is me
Rahat Ali Khan
This is me
Publication Date
January 15, 2013
Submission Date
January 15, 2013
Acceptance Date
-
Published in Issue
Year 2010 Volume: 15 Number: 2